- Report
- November 2021
- 120 Pages
Global
From €2211EUR$2,500USD£1,916GBP
- Report
- August 2023
- 85 Pages
United States
From €4289EUR$4,850USD£3,716GBP
- Report
- July 2025
- 88 Pages
Global
From €3500EUR$4,240USD£3,139GBP
- Report
- November 2024
- 101 Pages
Global
From €3500EUR$4,240USD£3,139GBP
- Report
- August 2024
- 98 Pages
Global
From €3500EUR$4,240USD£3,139GBP
The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs.
The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more
